JIPLP: So when is a patent claim too broad?

No items found.
01 July 2013
Tags
Litigation
Life

The Journal of Intellectual Property Law and Practice has published an article by Andrew Sharples and Carissa Kendall-Palmer about the Court of Appeal’s decision in Regeneron Pharmaceuticals Inc v Genentech Inc.

This ruling confirms that a broad claim in a patent encompassing a large number of unexemplified embodiments can be valid and enforceable.

To read the JIPLP article in full, click here.

Related articles

EIP recognised across the board in IAM Patent 1000, 2026
29 May 2026
We're pleased to be featured again in the IAM Patent 1000, 2026. The guide is one of the most trusted independent rankings of patent professionals worldwide, built on months of research and direct feedback from clients and peers.
Five EIP leaders recognised in WIPR 2026
11 May 2026
We are delighted to announce that five members of our team have been named in WIPR Leaders 2026: Jerome Spaargaren, Heather McCann, Gary Moss, Andrew Sharples, and Sebastian Fuchs.
EIP recognsied for strategic leadership in patent law at the Professional Services Management Excellence Awards
26 March 2026
EIP has been recognised with two Professional Services Management Excellence Awards 2026, including Excellence in Strategic Leadership and Best in Theme: Leadership. The awards reflect the firm’s commitment to aligning patent expertise with commercial insight, strengthening leadership across the firm and delivering patent strategy that supports investment, growth and high‑value business decisions.